Petefészekrák: nyitott vizsgálatok itt: Puerto Rico

• NCT06580314

  Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  Kísérleti kezelés · 3. fázis · NRG Oncology

  Cancer Center-Metro Medical Center Bayamon, Bayamón · Puerto Rico Hematology Oncology Group, Bayamón · Doctors Cancer Center, Manati · San Juan City Hospital, San Juan · San Juan Community Oncology Group, San Juan · Centro Comprensivo de Cancer de UPR, San Juan · PROncology, San Juan

  Regiszter frissítve: 2026-11-09

• NCT07546500

  A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

  Kísérleti kezelés · 3. fázis · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

  San Juan

  Regiszter frissítve: 2026-11-09

• NCT05879926

  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  Kísérleti kezelés · 3. fázis · NRG Oncology

  Puerto Rico Hematology Oncology Group, Bayamón · Cancer Center-Metro Medical Center Bayamon, Bayamón · Doctors Cancer Center, Manati · Centro Comprensivo de Cancer de UPR, San Juan · San Juan Community Oncology Group, San Juan · PROncology, San Juan · San Juan City Hospital, San Juan

  Regiszter frissítve: 2026-11-04

• NCT05564377

  Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  Kísérleti kezelés · 2. fázis · National Cancer Institute (NCI)

  Puerto Rico Hematology Oncology Group, Bayamón · Doctors Cancer Center, Manati · Centro Comprensivo de Cancer de UPR, San Juan · PROncology, San Juan

  Regiszter frissítve: 2026-11-02

• NCT05128825

  A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  Kísérleti kezelés · 2. fázis · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

  Site 0326 - Pan American Center for Oncology Trials LLC, San Juan

  Regiszter frissítve: 2026-10-30

• NCT07109726

  A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  Kísérleti kezelés · 1/2. fázis · Terremoto Biosciences Inc.

  PanOncology Trials, San Juan

  Regiszter frissítve: 2026-10-28

• NCT05645536

  Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

  Kísérleti kezelés · 3. fázis · Tolmar Inc.

  FDI Clinical Research, San Juan

  Regiszter frissítve: 2026-10-23

• NCT07214779

  Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  Kísérleti kezelés · 3. fázis · Incyte Corporation

  Brcr Global - Hato Rey, San Juan · BRCR Global- Yauco, Yauco

  Regiszter frissítve: 2026-10-15

• NCT06084481

  Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

  Kísérleti kezelés · 1. fázis · AbbVie

  Pan American Center for Oncology Trials - Rio Piedras /ID# 262903, Rio Piedras

  Regiszter frissítve: 2026-10-14

• NCT06128551

  Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  Kísérleti kezelés · 1/2. fázis · Revolution Medicines, Inc.

  Pan American Center for Oncology Trials, San Juan

  Regiszter frissítve: 2026-09-22

• NCT07023627

  A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  Kísérleti kezelés · 2. fázis · Incyte Corporation

  PanOncology Trials, San Juan

  Regiszter frissítve: 2026-09-15

• NCT03067181

  Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

  Kísérleti kezelés · 3. fázis · Children's Oncology Group

  HIMA San Pablo Oncologic Hospital, Caguas · San Jorge Children's Hospital, San Juan

  Regiszter frissítve: 2026-08-25

• NCT03452774

  SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  Kutatás · Massive Bio, Inc.

  San Juan

  Regiszter frissítve: 2025-10-28

Minden vizsgálat (Petefészekrák) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek